Aging brains pile up damaged proteins

(Press-News.org) As we age, we begin to lose the connections that wire up our brains—and neuroscientists aren’t sure why. 

It is increasingly clear, though, that the loss of synapses—the flexible and adaptive relay stations central to our brains’ ability to think, learn, and remember—is central to the rise of cognitive decline and dementia in old age.

Now, researchers supported by the Knight Initiative for Brain Resilience have discovered clues that may tie synapse loss to another hallmark of brain aging: the declining ability of brain cells to break down and recycle damaged proteins.

Published January 21, 2026, in Nature, the study shows that synaptic proteins are particularly susceptible to this age-related garbage-disposal problem: In old age, synaptic proteins break down much more slowly, they become more likely to pile up into the tangled clumps of protein characteristic of neurodegenerative disease, and they are more likely to make their way into microglia, immune cells that prune away damaged synapses.

Those findings are the latest in a series of discoveries that suggest new links between the brain’s waste management systems, microglia, and neurodegeneration—and they could yield new insights into human brain aging and neurodegeneration,  said the study’s lead author, Ian Guldner, an instructor in the Department of  Neurology and Neurological Sciences at Stanford Medicine. 

“We know that cognitive function and synapse density both decrease in aging human brains. We also see that microglia grow more dysfunctional with age. If microglia are taking in synapses’ damaged proteins, that could be overwhelming microglia and causing them to become dysfunctional. Overall, it would be a detrimental effect to brain health,” said Guldner, who works in the lab of Knight Initiative for Brain Resilience Director Tony Wyss-Coray, the D.H. Chen Professor of Neurology and Neurological Science at Stanford Medicine, and the study’s senior author.

New tools for probing proteins The new results emerged from a broader project aimed at understanding the lifecycle of neuronal proteins and how that changes with age, part of a collaboration with Carolyn Bertozzi, the Baker Family Director of Sarafan ChEM-H and the Anne T. and Robert M. Bass Professor in the Stanford School of Humanities and Sciences.

Using engineered tracking proteins inspired by Bertozzi’s Nobel Prize-winning work on biorthogonal chemistry, Guldner and team developed a two-step tagging process. 

First, they genetically modified an enzyme that helps add an amino acid, a building block of proteins, to proteins as they’re being built. Second, they created a new amino acid—one not found in nature—with a special tag. The modified enzyme is designed to attach only to that tagged amino acid, then ferry it to freshly built proteins, thereby tagging them.

The team used this process to measure the lifespan of neuronal proteins, asking how long new proteins typically last in the brain before getting broken down and recycled for parts.

The researchers could also ask how these protein life-cycles might change at different phases of a mouse’s lifespan: in young adulthood (four weeks), middle age (12 months), and old age (24 months).

They discovered that, compared with young and middle-aged mice, old mice took twice as long on average to break down proteins for recycling—a sign that protein balancing systems were in significant decline. 

Proteins were also more likely to clump up into plaque-like aggregates in older mice, the team found, which could be linked to the accumulation of such cellular garbage in many neurodegenerative disorders.

These two findings might be linked, Guldner hypothesized: Perhaps proteins take a long time to recycle precisely because they’re aggregating into a form that’s harder to chew up and dispose of.

The synaptic link The research also shed light on the question of why synapses are among the first casualties of neurodegenerative disorders. 

The study found that—for reasons not yet understood—synaptic proteins are more likely to degrade slowly in old age than other neuronal proteins. And these long-lasting synaptic proteins were also more likely than other proteins to spill over into microglia, whose role in synapse pruning is thought to be a key antecedent of Alzheimer’s disease and neurodegeneration. 

Within microglia, many synaptic proteins wound up in lysosomes, the machines within cells that break down proteins and other materials. 

That’s consistent with a growing line of work that’s linked lysosome dysfunction to neurodegenerative disease. (The team collaborated with the lab of Monther Abu-Remaileh, a Sarafan ChEM-H Institute Scholar and an assistant professor of chemical engineering in the School of Engineering and of genetics in the School of Medicine, on this aspect of the new research.)

Taken altogether, the findings may contribute to an emerging view that neurodegenerative disease is closely linked to failing waste management in the brain: When cells can no longer effectively break down damaged proteins, the proteins form heaps of garbage that build up in neurons and microglia, potentially disrupting their proper function.

One open question is why synaptic proteins appear to be particularly susceptible to this breakdown, and whether this helps explain why synapses are among the first victims of neurodegenerative disease. 

“We didn’t set out to understand the synapse specifically, but rather the mechanisms behind the decline in general neuron health and function with age,” Guldner said. “We just so happened to arrive at synaptic proteins being particularly vulnerable to slowed breakdown and aggregation.”

Another question for future research, Guldner said, would be to determine what effect damaged neuronal proteins have on microglial function and health and—since microglia play an important role in pruning synapses that are damaged or no longer needed—what the consequences may be for synapse loss and cognitive decline.

The study may also lay foundations for something of more immediate clinical relevance: using their tagging method to track neuronal proteins as they travel outside the brain, providing a valuable warning sign when protein recycling begins to go awry. 

“If we can leverage our system to study neuron-derived proteins in the blood during aging and disease, we could potentially identify new biomarkers of brain health,” Guldner said—potentially helping doctors identify Alzheimer’s and other diseases earlier than before.

END